Dr. Martens PLC (DOCS) - Total Assets
Based on the latest financial reports, Dr. Martens PLC (DOCS) holds total assets worth GBX865.40 Million GBX (≈ $105.29K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See DOCS book value for net asset value and shareholders' equity analysis.
Dr. Martens PLC - Total Assets Trend (2014–2025)
This chart illustrates how Dr. Martens PLC's total assets have evolved over time, based on quarterly financial data.
Dr. Martens PLC - Asset Composition Analysis
Current Asset Composition (March 2025)
Dr. Martens PLC's total assets of GBX865.40 Million consist of 46.2% current assets and 53.8% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 17.5% |
| Accounts Receivable | GBX56.80 Million | 6.4% |
| Inventory | GBX187.40 Million | 21.1% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX33.30 Million | 3.7% |
| Goodwill | GBX240.70 Million | 27.1% |
Asset Composition Trend (2014–2025)
This chart illustrates how Dr. Martens PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see DOCS market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dr. Martens PLC's current assets represent 46.2% of total assets in 2025, an increase from 24.7% in 2014.
- Cash Position: Cash and equivalents constituted 17.5% of total assets in 2025, up from 7.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, a decrease from 70.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 27.1% of total assets.
Dr. Martens PLC Competitors by Total Assets
Key competitors of Dr. Martens PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
On Holding Ltd
NYSE:ONON
|
USA | $2.75 Billion |
|
Zhejiang Red Dragonfly Footwear Co Ltd
SHG:603116
|
China | CN¥3.67 Billion |
|
Zhejiang Aokang Shoes Co Ltd
SHG:603001
|
China | CN¥3.12 Billion |
|
Baiksan
KO:035150
|
Korea | ₩454.19 Billion |
|
Grimoldi SA
BA:GRIM
|
Argentina | AR$187.11 Billion |
|
Merchant House International Ltd
AU:MHI
|
Australia | AU$24.11 Million |
|
Vulcabras Azaleia S.A
SA:VULC3
|
Brazil | R$3.88 Billion |
|
Grendene S.A
SA:GRND3
|
Brazil | R$4.52 Billion |
Dr. Martens PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.18 | 2.26 | 2.03 |
| Quick Ratio | 1.08 | 0.99 | 1.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX214.80 Million | GBX243.20 Million | GBX189.10 Million |
Dr. Martens PLC - Advanced Valuation Insights
This section examines the relationship between Dr. Martens PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.01 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -6.6% |
| Total Assets | GBX889.80 Million |
| Market Capitalization | $7.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dr. Martens PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dr. Martens PLC's assets decreased by 6.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dr. Martens PLC (2014–2025)
The table below shows the annual total assets of Dr. Martens PLC from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | GBX889.80 Million ≈ $108.26K |
-6.57% |
| 2024-03-31 | GBX952.40 Million ≈ $115.88K |
-4.05% |
| 2023-03-31 | GBX992.60 Million ≈ $120.77K |
+15.54% |
| 2022-03-31 | GBX859.10 Million ≈ $104.53K |
+31.60% |
| 2021-03-31 | GBX652.80 Million ≈ $79.43K |
-0.56% |
| 2020-03-31 | GBX656.50 Million ≈ $79.88K |
+45.82% |
| 2019-03-31 | GBX450.20 Million ≈ $54.78K |
+0.99% |
| 2018-03-31 | GBX445.80 Million ≈ $54.24K |
+6.09% |
| 2017-03-31 | GBX420.20 Million ≈ $51.13K |
+11.76% |
| 2016-03-31 | GBX376.00 Million ≈ $45.75K |
+3.52% |
| 2015-03-31 | GBX363.20 Million ≈ $44.19K |
+6.46% |
| 2014-03-31 | GBX341.15 Million ≈ $41.51K |
-- |
About Dr. Martens PLC
Dr. Martens plc engages in the design, development, procurement, marketing, sale, and distribution of footwear. The company sells its footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.